FDA Urges Court To Keep Abortion Drug Regulations Intact
The U.S. Food and Drug Administration told a Washington federal court that Democratic state attorneys general waited for more than two decades to challenge restrictions on abortion medication mifepristone, which in...To view the full article, register now.
Already a subscriber? Click here to view full article